RBM39 Enhances Cholangiocarcinoma Growth Through EZH2-mediated WNT7B/β-catenin Pathway

Nianli Liu(Xuzhou Medical College), Tong Wu(Tulane University)

Cellular and Molecular Gastroenterology and Hepatology

September 14, 2024

10.1016/j.jcmgh.2024.101404

Cited by 9

Related Papers

miR-185 Inhibits Hepatocellular Carcinoma Growth by Targeting the DNMT1/PTEN/Akt Pathway

|American Journal Of Pathology|2014|100

miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT

|PLoS ONE|2015|27